Cargando…

Short Research Communication Anti-Spike Antibody Response to COVISHIELD™ (SII-ChAdOx1 nCoV-19) Vaccine in Patients with B-Cell and Plasma Cell Malignancies and Hematopoietic Cell Transplantation Recipients

INTRODUCTION: There is limited data on the serologic antibody responses after the ChAdOx1 vaccine in patients with hematological malignancies and hematopoietic cell transplantation recipients. There is no data on the safety and efficacy of the Indian COVISHIELD™ vaccine in this population. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Chopra, Madhu, Jain, Arihant, Chhabra, Sanjeev, Kaundal, Shaweta, Singh, Charanpreet, Jandial, Aditya, Prakash, Gaurav, Khadwal, Alka, Das, Chandan, Singh, Mini P, Das, Reena, Malhotra, Pankaj, Lad, Deepesh P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891427/
https://www.ncbi.nlm.nih.gov/pubmed/35261492
http://dx.doi.org/10.1007/s12288-022-01528-y